Chugai Pharmaceutical Co. Ltd. - Total Cashflows From Financing Activities

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Total-Cashflows-From-Financing-Activities" stands at -307.28 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 03/31/2012, the period currently displayed.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of -207.67 Billion JPY for the item "Total Cashflows From Financing Activities" represents a decrease of -8,729.42 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of -207.67 Billion JPY for the item "Total Cashflows From Financing Activities" represents a decrease of -198.78 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of -307.28 Billion JPY for the item "Total Cashflows From Financing Activities" represents a decrease of -81.69 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -166.09 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -166.09 Billion Japanese Yens.
The 3 year change is -161.02 Billion Japanese Yens.
The 5 year change is -207.94 Billion Japanese Yens.
The 10 year change is -279.03 Billion Japanese Yens.

The Serie's long term average value is -73.77 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -233.51 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2013, to it's latest available value, on 09/30/2025, is -285.04 Billion.